AI-generated summary
The authors studied 12 drug-free patients with seasonal affective disorder who were in remission after bright light therapy. Using a double-blind, placebo-controlled crossover design, they lowered tryptophan levels and reported that this led to a transient depressive relapse, most pronounced the day after testing. The authors conclude that maintaining light therapy-induced remission may depend on the brain serotonin system, though the study was small and only in those with this condition.
- Participants
- 12
- Who or what was studied
- Drug-free adults with seasonal affective disorder in clinical remission after bright light therapy
- Limits stated in the abstract
- Small sample of 12 patients, and the abstract does not describe how the serotonin link was established beyond the depletion effect.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on archpsyc.jamanetwork.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.